Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

Register

Sign In

EUR/USD

1.1753

-0.0040

-0.34%

GBP/USD

1.3185

-0.0061

-0.46%

USD/JPY

112.37

0.1965

0.18%

USD/CHF

0.9792

0.0037

0.38%

EUR/GBP

0.8913

0.0011

0.12%

USD/CAD

1.2539

0.0019

0.15%

NZD/USD

0.7166

-0.0020

-0.28%

EUR/JPY

132.06

-0.2140

-0.16%

EUR/CHF

1.1508

0.0005

0.04%

Akers Biosciences Inc.

NASDAQ: AKERHealthcare / Medical Instruments & Supplies / USA
0.89-0.16-15.24%Vol 1 028 2501Y Perf -73.03%
Oct 16th, 2017 15:59
BID0.88 ASK0.89
Open1.08 Previous Close1.05
Pre-Market0.89 After-Trading0.89
 - -%  - -%
Target Price
- 
Analyst Rating
— 0.00
Potencial %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)8 
Earnings Rating
Buy
Price Range Ratio 52wk %
6.55 
Earnings Date
13th Nov 2017

Today's Price Range

0.871.09

 

52wk Range

0.703.60

Summary:

Neutral

Technical Indicators: Buy
Moving Averages: Strong Sell
Performance
1 Month
-6.32%
3 Months
-22.61%
6 Months
-44.38%
1 Year
-73.03%
3 Years
-71.38%
5 Years
-
Last Quotes
Name / TickerPriceChg.Chg.%
AKER0.89-0.1600-15.24
AAPL159.882.89001.84
GOOG992.002.32000.23
MSFT77.650.16000.21
XOM82.810.40000.49
WFC53.800.11000.20
JNJ136.12-0.3100-0.23
FB174.520.78000.45
GE23.360.38001.65
JPM97.841.98002.07
...

TickerPriceChg.%52 Week High
DVA56.934.0270.16
FCX15.273.5317.06
WYNN146.813.15150.40
NBL27.902.7642.03
APA42.732.7269.00
MU41.492.7042.07
HES46.042.3365.56
DFS65.352.3074.33
SYF31.502.2138.06
NRG26.622.1526.68
JPM97.842.0797.95
AMAT55.042.0455.09
BWA52.172.0352.71
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 1.60
Current Ratio 3.40
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -697.70
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin63.90
EBIT Margin-90.30
EBITDA Margin-80.90
Pre-tax Profit Margin-170.40
Profit Margin-91.32
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 1.85
PS Ratios 0.05
Price to Cash Flow 44.60
Price to Free Cash Flow -2.60
Cash Flow Per Share -0.49
Price to Tangible Book2.38
Book Value per Share0.57
Enterprise Value (in ths.)8 235
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-61.87
ROE last 12 Months -61.27
Return on Assets (5Y Avg) -57.78
ROA last 12 Months -46.21
Return on Capital (5Y Avg) -55.57
ROC last 12 Months -60.88
Return on invested Capital Q -12.34
Return on invested Capital Y-66.57
Assets Turnover0.40
Receivables Turnover3.10
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)2 518
Revenue per Share 23.07
Revenue Growth 3 Years -3.12
Revenue Growth 5 Years 12.11
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2016--0.19-
Q01 2016--0.28-
Q04 2015--0.69-
Q03 2015--0.36-
Q02 2015--0.41-
Q01 2015--0.26-
Q04 2014--0.19-
Q03 2014--0.23-
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date13th Nov 2017
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume1 028 250
Shares Outstanding (in ths.)8 900
Trades Count1 343
Dollar Volume932 233
Avg. Volume159 293
Avg. Weekly Volume1 524 557
Avg. Monthly Volume445 539
Avg. Quarterly Volume186 289

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

100%0%

Bearish Bullish

67%33%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Strong Buy
1.00

There are no comments yet.

News

x